Funding round brings in $15M for Pa. biotech

05/6/2013 | American City Business Journals

AltheRx Pharmaceuticals secured $15 million in its latest funding round. The Exton, Pa.-based firm plans to use the money to bring Solabegron, its lead drug candidate for overactive bladder, into late-stage trials. AltheRx also appointed Jim Bennethum, former executive vice president of Becker Ventures, as its new CEO.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT